Healthcare stocks showed a healthy gain on Tuesday as the sector pushed forward 0.41% with several companies posting impressive double-digit percentage jumps including IntelliPharmaCeutics International, Inc. (NASDAQ: IPCI) which soared 36.99% to close at 4.00 on the day. Volume for the company, which engages in the research, development, and manufacture of novel and generic controlled and targeted release oral solid dosage drugs, was more than 15x its average as shares climbed to a six-month high of 4.20. Shares are currently trading above the 50-day moving average of 2.76 and 200-day moving average of 2.60.
After shares dropped significantly following a 0.90 high on January 6 when they announced that they had entered into a credit agreement with LSQ Funding Group, L.C. that would provide for borrowings up to $2 million for working capital requirements and other general corporate purposes NMT Medical, Inc. (NASDAQ: NMTI) bounced back on Tuesday to surge 14.85% to close at 0.611. The company, which designs, develops, manufactures, and markets implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive catheter-based procedures, is now trading nearly twice as high as the 50-day moving average of 0.31 yet remains well below the 200-day moving average of 1.28.
Grupo Csa Saba, S.A. (ADR) (NYSE: SAB), a company that operates as a multi-channel and multi-product wholesale distributor in Mexico, the United States, saw shares spike 13.33% on Tuesday to close at 17.00 on nearly 5x it’s average trading volume. The strong performance pushed shares to a six-month high and kept them above the 50-day moving average of 13.73 as well as the 200-day moving average of 13.91.
With trading volume topping 3x its average shares in Gentium S.p.A (ADR) (NASDAQ: GENT) pushed forward 11.71% on Tuesday to close at 7.92. The company, which focuses on the development and manufacture of drugs to treat and prevent various diseases and conditions, including vascular diseases related to cancer and cancer treatments, climbed as high as 8.60 to set a 52-week high and shares are currently ahead of their 50-day moving average of 5.98 and their 200-day moving average of 5.23.
Following news that Auriga U.S.A has upgraded HeartWare International, Inc. (NASDAQ: HTWR) from a “hold” to a “buy” shares in the company climbed 11.51% to close at 96.19. The company, which engages in the design, manufacture, and marketing of medical devices for the treatment of advanced heart failure, climbed as high as 99.00 to set a new 52-week high and shares remain well above the 50-day moving average of 84.91 and 200-day moving average of 67.98.